Academic Journal
Q1Biomarker Research
About Biomarker Research
Biomarker Research is a scholarly journal published by BioMed Central Ltd. SCImago 2025 lists it in Q1, with an SJR of 3.303 and H-index of 69.
Coverage: 2013-2026. Research categories: Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Molecular Medicine (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Beyond hypoxia and ccRCC: the expanding universe of VHL novel targets and next-generation therapeutics
Ruiyi Deng, Boyuan Wang, Mingrui Zou, Kaiyuan Mao et al.
2026-09-09 · DOI: 10.1186/s40364-026-00986-0AI-driven precision immunotherapy: emerging trends from AACR 2026
Yani Chen, Ming Chen, Yiqing Xi, Yun Xia et al.
2026-09-09 · DOI: 10.1186/s40364-026-00995-zIntegrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer
Ilaria Cassotti, Vito Fiume, Paolo Gandellini, Clelia Tiziana Storlazzi et al.
2026-09-05 · DOI: 10.1186/s40364-026-00991-3Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
Wenwen Cheng, Silvia Gaggero, Lama Hasan Bou Issa, Aïcha Ouelkdite et al.
2026-09-05 · DOI: 10.1186/s40364-026-00992-2Mapping brain volume changes in the zQ175DN mouse model of Huntington’s disease: a longitudinal MRI study
Nicholas Vidas-Guscic, Tamara Vasilkovska, Stefanie Pluym, Joëlle van Rijswijk et al.
2026-09-01 · DOI: 10.1186/s40364-026-00971-7Evaluating global clinical trials and development trends of antibody-drug conjugates
Jintao Hu, Cong Lai, Junjie Wang, Zi Yan et al.
2026-08-28 · DOI: 10.1186/s40364-026-00994-0Intra-aortic balloon pump use and in-hospital mortality in acute myocardial infarction with Killip class III or IV: a nationwide cohort study
Lingsen You, Hao Li, Zhenzhen Lu, Yu Wang et al.
2026-08-26 · DOI: 10.1186/s40364-026-00993-1From molecular pathogenesis to novel Therapeutic approaches - a review of recent advances in the treatment of peripheral T cell Lymphomas
Wee Lee Chan, Wee Joo Chng, Qi-Jing Li
2026-08-25 · DOI: 10.1186/s40364-026-00985-1HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs
Xu Shi, Zehua Tan, Guangxi Sun, Hao Zeng et al.
2026-08-24 · DOI: 10.1186/s40364-026-00990-4Multidimensional 5-hydroxymethylcytosine features in cell-free DNA enable the detection, staging and subtyping of pancreatic ductal adenocarcinoma
Haoyu Shi, Cheng Qin, Yutong Zhao, Lirui Huang et al.
2026-08-24 · DOI: 10.1186/s40364-026-00988-yImmuno-PET imaging of mesothelin in ovarian cancer with 68Ga-XH04: a first-in-human study
Yueling Deng, Xiao Zhang, Zhidi Pan, Xiaoying Lv et al.
2026-08-24 · DOI: 10.1186/s40364-026-00989-xThe role of biomarkers across the care continuum in acute heart failure
Arzu Kalayci, C. Michael Gibson, James L. Januzzi
2026-08-14 · DOI: 10.1186/s40364-026-00987-zClinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study
Gaku Yamamichi, Taigo Kato, Atsuki Matsukawa, Nanae Masunaga et al.
2026-08-12 · DOI: 10.1186/s40364-026-00982-4FECH, a novel metabolic target influencing CAR T-cell phenotype and function
Marsha Pellegrino, Simone Vespa, Illari Salvatori, Giang Dang Mac et al.
2026-08-12 · DOI: 10.1186/s40364-026-00979-zKRAS signaling networks, mutational heterogeneity, and emerging therapeutic strategies for cancer treatment
Shikai Jin, Zinan Zhang, Fuchao Liang, Yang Yang et al.
2026-08-11 · DOI: 10.1186/s40364-026-00981-5PD-L1+ exosomes as biomarkers and therapeutic targets in multiple myeloma: implications for CAR-T efficacy and combination immunotherapy
Peng Xu, Wen-Jie Yu, Si-Han Wu, Yang Liu et al.
2026-08-11 · DOI: 10.1186/s40364-026-00980-6Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence era
Xinyue Zeng, I. Weng Lao, Yifeng Sun, Qifeng Wang et al.
2026-08-10 · DOI: 10.1186/s40364-026-00983-3Targeting breast cancer stem cells by restoring RBM38 function: mechanism and protein delivery therapy
Jun Yin, Ting Wang, Xuedan Han, Ying Chen et al.
2026-08-10 · DOI: 10.1186/s40364-026-00984-2Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer
Ru-yan Xiao, Ye-fan Jiang, Wei Zhao, Qing-qing Wang et al.
2026-08-07 · DOI: 10.1186/s40364-026-00978-0Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025
Zezhou Zang, Wei Zheng, Ruirong Xu, Siyuan Cui et al.
2026-08-05 · DOI: 10.1186/s40364-026-00977-1Reviews
Community Reviews
Version History
September 14, 2026 at 2:15 am
September 14, 2026